WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
Postboks 222 Sk°yen
0213 Oslo
Norway

Visiting/delivery address:
Sandakerveien 24C
Bygg C
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

C CARDIOVASCULAR SYSTEM
C10 LIPID MODIFYING AGENTS

The DDDs are based on the treatment of hypercholesterolemia.


C10A LIPID MODIFYING AGENTS, PLAIN

Pantethine, which is also used in the treatment of hyperlipidemi, is classified as a vitamin in A11HA.


C10AD Nicotinic acid and derivatives

This group comprises high strength preparations (e.g. nicotinic acid tab 500 mg) used as cholesterol reducers. Nicotinic acid or derivatives in low strength preparations (e.g. nicotinic acid tab 50 mg) are classified in C04A - Peripheral vasodilators.

Combinations of nicotinic acid and laropiprant are classified in C10AD52.


    ATC code  Name  DDD  U Adm.R Note
    C10AD02 nicotinic acid 

List of abbreviations

Last updated: 2018-12-13